Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway
about
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunityHuman immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Mechanisms of Cross-protection by Influenza Virus M2-based VaccinesComplement receptor mediates enhanced flavivirus replication in macrophagesRole of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodiesThe structural immunology of antibody protection against West Nile virusHeterozygous C2 deficiency associated with angioedema, myasthenia gravis, and systemic lupus erythematosusSerum complement components in patients with trachomaThe resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.Disassembly of viral membranes by complement independent of channel formationGuinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.Complement and HIV-I infection/HIV-associated neurocognitive disorders.Genetic control of a mouse serum lipoprotein factor that inactivates murine leukemia viruses: evaluation of apolipoprotein F as a candidate.Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophagesRetrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complementAntibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entryImmune complexes in human diseases: a reviewComplement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashionComplement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodiesInhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expressionLysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15ERole of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.Activation of complement by cells infected with respiratory syncytial virus.T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster seraNeutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis.C1q, a subunit of the first component of complement, enhances binding of plasma fibronectin to bacteria.Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.The complement system: its importance in the host response to viral infection.Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.Virolysis of mouse mammary tumor virus by sera from breast cancer patients.Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies.Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer.Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.Complement in the pathophysiology and diagnosis of human diseases.Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.
P2860
Q24672388-977542F4-FFAB-4CF0-B5EE-1A3147C4ECB8Q24675546-F967B967-C590-474F-AD50-C63FF6EE44FCQ26777740-22F38F35-F554-48A5-878F-6AD6D31CC164Q27485068-B99CD0A8-30FF-4A57-B3B3-A7F171C8396EQ27486933-0F57CA41-B4E2-4705-849C-1CB85004755EQ27487955-C07B0C25-C0CB-4CB6-85ED-5EBB514AE7B0Q33556658-E0404B5B-59C8-4A62-BAFE-6421DF132682Q33644446-178736BE-C40B-4B94-9BF7-2D2994A9808EQ33817487-E20255D7-18ED-44E1-8FED-291A6B6D6357Q33981914-B5108A46-73CB-43EC-8E5E-48A1D85580C4Q34537829-E52C21D9-1D96-4FB3-98BA-7B8D958199D0Q34610122-447ED7A2-C4C6-47B9-8969-4E17E6FED085Q34969506-9C4C21D0-7F34-4247-876D-AC954CEB20F7Q35313833-5B8E86C9-403C-4E3C-A3C8-0B551193D18CQ35580131-5FFDAE05-9ADF-4117-B57D-73631345DF99Q35763321-3FA59952-434B-494C-81EA-6322D0DE8755Q35857748-838F2309-79AB-408D-8B77-6BCBEDFF6FEEQ35863255-D165A91B-6C6E-4751-B819-9BE786FFD33BQ36230054-C4DFC09D-6C8B-4979-8E59-BF147B87D119Q36296755-4197099A-7293-4780-88EE-990624E146E3Q36335418-28039E9A-6409-45F6-8E12-97A2D798F876Q36339984-67589535-7256-4817-996C-D0009FEEA147Q36365174-1466E149-0753-470E-A1C2-94EB29315F6EQ36365516-CAC0EE3E-915F-4576-8FE0-BE65E0D75050Q36423647-606C040D-2DF5-4E5D-97E3-0DEF0F3831ECQ36467689-7AF08336-149A-4AD6-B70C-EF896D68CD39Q36651916-49E10CE1-A253-4EDB-9FCA-042DEFB37444Q36795915-DA41B926-2EC4-4E46-B198-16C632928FF3Q37033325-B90E301B-554E-4F93-97C2-80C7B5E1FACAQ37046896-39FFE367-B5BD-4B7B-A655-76EEC7EFA458Q37066281-1BAECB04-0C89-4ADA-8E75-DD492BAA9459Q37256174-BEF37164-7743-4156-B68F-F23BCDA2D251Q37334319-8413B9C0-C57E-4AC0-8D07-3D729C187B72Q37335492-5877916E-9601-417D-9040-6765DB49534BQ37595738-C0B20566-B69C-4054-AA57-A0D5059EB819Q38646953-A6E9AAA1-FE3E-4159-8F8E-FA331DDB26CCQ39487716-8E3FBCCB-D48A-4863-A051-081FEBB087D3Q39580367-D9612E3E-8B5E-4CC7-A1F7-A6A9E693AAC9Q39644772-82D2D1A4-BC76-42A9-96BD-CD79A26482C2Q40042967-54814EF8-A5C1-4960-B1AB-2A0EB4B709AF
P2860
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Lysis of RNA tumor viruses by ...... e classical complement pathway
@ast
Lysis of RNA tumor viruses by ...... e classical complement pathway
@en
type
label
Lysis of RNA tumor viruses by ...... e classical complement pathway
@ast
Lysis of RNA tumor viruses by ...... e classical complement pathway
@en
prefLabel
Lysis of RNA tumor viruses by ...... e classical complement pathway
@ast
Lysis of RNA tumor viruses by ...... e classical complement pathway
@en
P2093
P2860
P356
P1476
Lysis of RNA tumor viruses by ...... e classical complement pathway
@en
P2093
Oldstone MB
Welsh RM Jr
P2860
P304
P356
10.1084/JEM.144.4.970
P407
P577
1976-10-01T00:00:00Z